Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 135 entries
Sorted by: Best Match Show Resources per page
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice.

Therapeutic advances in medical oncology

Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA.
PMID: 29449894
Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19.

BACKGROUND: Regorafenib (REG) has now been approved as the standard third-line therapy in metastatic gastrointestinal stromal tumour (GIST) patients at the recommended dose and schedule of 160 mg once daily for the first 3 weeks of each 4-week cycle....

Cite
Nannini M, Nigro MC, Vincenzi B, et al. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017;9(12):731-739doi: 10.1177/1758834017742627.
Nannini, M., Nigro, M. C., Vincenzi, B., Fumagalli, E., Grignani, G., D'Ambrosio, L., Badalamenti, G., Incorvaia, L., Bracci, R., Gasperoni, S., Saponara, M., Gatto, L., Indio, V., Astolfi, A., Di Scioscio, V., Casali, P. G., Tonini, G., Aglietta, M., Russo, A., Biasco, G., & Pantaleo, M. A. (2017). Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Therapeutic advances in medical oncology, 9(12), 731-739. https://doi.org/10.1177/1758834017742627
Nannini, Margherita, et al. "Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice." Therapeutic advances in medical oncology vol. 9,12 (2017): 731-739. doi: https://doi.org/10.1177/1758834017742627
Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19. PMID: 29449894; PMCID: PMC5808843.
Copy Download .nbib Format: NLM
Arthroscopic anterior shoulder capsulorrhaphy.

Sports medicine and arthroscopy review

Caspari RB, Beach WR.
PMID: 17630536
Sports Med Arthrosc Rev. 1993;1(4):237-41. doi: 10.1097/00132585-199300140-00001.

Shoulder dislocation is a common cause of upper extremity disability. The recurrence rate is inversely proportional to the patient's age at the initial dislocation. There are several pathologic variations of anterior/inferior glenohumeral ligament laxity. The indications, contraindications, as well...

Cite
Caspari RB, Beach WR. Arthroscopic anterior shoulder capsulorrhaphy. Sports Med Arthrosc Rev. 1993;1(4):237-41doi: 10.1097/00132585-199300140-00001.
Caspari, R. B., & Beach, W. R. (1993). Arthroscopic anterior shoulder capsulorrhaphy. Sports medicine and arthroscopy review, 1(4), 237-41. https://doi.org/10.1097/00132585-199300140-00001
Caspari, R B, and Beach, W R. "Arthroscopic anterior shoulder capsulorrhaphy." Sports medicine and arthroscopy review vol. 1,4 (1993): 237-41. doi: https://doi.org/10.1097/00132585-199300140-00001
Caspari RB, Beach WR. Arthroscopic anterior shoulder capsulorrhaphy. Sports Med Arthrosc Rev. 1993;1(4):237-41. doi: 10.1097/00132585-199300140-00001. PMID: 17630536.
Copy Download .nbib Format: NLM
Quantitative Biology.

Science (New York, N.Y.)

Caspari E.
PMID: 17746057
Science. 1951 Sep 07;114(2958):3. doi: 10.1126/science.114.2958.3.

No abstract available.

Cite
Caspari E. Quantitative Biology. Science. 1951;114(2958):3doi: 10.1126/science.114.2958.3.
Caspari, E. (1951). Quantitative Biology. Science (New York, N.Y.), 114(2958), 3. https://doi.org/10.1126/science.114.2958.3
Caspari, E. "Quantitative Biology." Science (New York, N.Y.) vol. 114,2958 (1951): 3. doi: https://doi.org/10.1126/science.114.2958.3
Caspari E. Quantitative Biology. Science. 1951 Sep 07;114(2958):3. doi: 10.1126/science.114.2958.3. PMID: 17746057.
Copy Download .nbib Format: NLM
The Influence of Cytoplasmic Pollen Sterility on Gene Exchange between Populations.

Genetics

Caspari E, Watson GS, Smith W.
PMID: 17248302
Genetics. 1966 Apr;53(4):741-6. doi: 10.1093/genetics/53.4.741.

No abstract available.

Cite
Caspari E, Watson GS, Smith W. The Influence of Cytoplasmic Pollen Sterility on Gene Exchange between Populations. Genetics. 1966;53(4):741-6doi: 10.1093/genetics/53.4.741.
Caspari, E., Watson, G. S., & Smith, W. (1966). The Influence of Cytoplasmic Pollen Sterility on Gene Exchange between Populations. Genetics, 53(4), 741-6. https://doi.org/10.1093/genetics/53.4.741
Caspari, E, et al. "The Influence of Cytoplasmic Pollen Sterility on Gene Exchange between Populations." Genetics vol. 53,4 (1966): 741-6. doi: https://doi.org/10.1093/genetics/53.4.741
Caspari E, Watson GS, Smith W. The Influence of Cytoplasmic Pollen Sterility on Gene Exchange between Populations. Genetics. 1966 Apr;53(4):741-6. doi: 10.1093/genetics/53.4.741. PMID: 17248302; PMCID: PMC1211054.
Copy Download .nbib Format: NLM
Close Linkage between Mutations with Similar Effects.

Proceedings of the National Academy of Sciences of the United States of America

Dunn LC, Caspari E.
PMID: 16588544
Proc Natl Acad Sci U S A. 1942 May;28(5):205-10. doi: 10.1073/pnas.28.5.205.

No abstract available.

Cite
Dunn LC, Caspari E. Close Linkage between Mutations with Similar Effects. Proc Natl Acad Sci U S A. 1942;28(5):205-10doi: 10.1073/pnas.28.5.205.
Dunn, L. C., & Caspari, E. (1942). Close Linkage between Mutations with Similar Effects. Proceedings of the National Academy of Sciences of the United States of America, 28(5), 205-10. https://doi.org/10.1073/pnas.28.5.205
Dunn, L C, and Caspari, E. "Close Linkage between Mutations with Similar Effects." Proceedings of the National Academy of Sciences of the United States of America vol. 28,5 (1942): 205-10. doi: https://doi.org/10.1073/pnas.28.5.205
Dunn LC, Caspari E. Close Linkage between Mutations with Similar Effects. Proc Natl Acad Sci U S A. 1942 May;28(5):205-10. doi: 10.1073/pnas.28.5.205. PMID: 16588544; PMCID: PMC1078449.
Copy Download .nbib Format: NLM
Phylogeny: Principles and Methods.

Science (New York, N.Y.)

Caspari E.
PMID: 17829128
Science. 1963 Feb 22;139(3556):773-4. doi: 10.1126/science.139.3556.773.

No abstract available.

Cite
Caspari E. Phylogeny: Principles and Methods. Science. 1963;139(3556):773-4doi: 10.1126/science.139.3556.773.
Caspari, E. (1963). Phylogeny: Principles and Methods. Science (New York, N.Y.), 139(3556), 773-4. https://doi.org/10.1126/science.139.3556.773
Caspari, E. "Phylogeny: Principles and Methods." Science (New York, N.Y.) vol. 139,3556 (1963): 773-4. doi: https://doi.org/10.1126/science.139.3556.773
Caspari E. Phylogeny: Principles and Methods. Science. 1963 Feb 22;139(3556):773-4. doi: 10.1126/science.139.3556.773. PMID: 17829128.
Copy Download .nbib Format: NLM
Rare cancers: work in progress in Europe.

Annals of oncology : official journal of the European Society for Medical Oncology

Casali PG.
PMID: 24667726
Ann Oncol. 2014 Apr;25(4):914. doi: 10.1093/annonc/mdu033.

No abstract available.

Cite
Casali PG. Rare cancers: work in progress in Europe. Ann Oncol. 2014;25(4):914doi: 10.1093/annonc/mdu033.
Casali, P. G. (2014). Rare cancers: work in progress in Europe. Annals of oncology : official journal of the European Society for Medical Oncology, 25(4), 914. https://doi.org/10.1093/annonc/mdu033
Casali, P G. "Rare cancers: work in progress in Europe." Annals of oncology : official journal of the European Society for Medical Oncology vol. 25,4 (2014): 914. doi: https://doi.org/10.1093/annonc/mdu033
Casali PG. Rare cancers: work in progress in Europe. Ann Oncol. 2014 Apr;25(4):914. doi: 10.1093/annonc/mdu033. PMID: 24667726.
Copy Download .nbib Format: NLM
Effect of boundary conditions on the critical behavior of a fi- nite high-dimensional Ising model.

Physical review. B, Condensed matter

Gaspari G, Privman V, Rudnick J.
PMID: 9936919
Phys Rev B Condens Matter. 1985 Dec 01;32(11):7594-7596. doi: 10.1103/physrevb.32.7594.

No abstract available.

Cite
Gaspari G, Privman V, Rudnick J. Effect of boundary conditions on the critical behavior of a fi- nite high-dimensional Ising model. Phys Rev B Condens Matter. 1985;32(11):7594-7596doi: 10.1103/physrevb.32.7594.
Gaspari, G., Privman, V., & Rudnick, J. (1985). Effect of boundary conditions on the critical behavior of a fi- nite high-dimensional Ising model. Physical review. B, Condensed matter, 32(11), 7594-7596. https://doi.org/10.1103/physrevb.32.7594
Gaspari, et al. "Effect of boundary conditions on the critical behavior of a fi- nite high-dimensional Ising model." Physical review. B, Condensed matter vol. 32,11 (1985): 7594-7596. doi: https://doi.org/10.1103/physrevb.32.7594
Gaspari G, Privman V, Rudnick J. Effect of boundary conditions on the critical behavior of a fi- nite high-dimensional Ising model. Phys Rev B Condens Matter. 1985 Dec 01;32(11):7594-7596. doi: 10.1103/physrevb.32.7594. PMID: 9936919.
Copy Download .nbib Format: NLM
Evidence for Naturally Occurring Electron Capture of 123Te.

Physical review letters

Alessandrello A, Brofferio C, Bucci C, Camin DV, Caspani P, Colling P, Cremonesi O, Fiorini E, Giuliani A, Nucciotti A, Pavan M, Pessina G, Previtali E, Zanotti L.
PMID: 10062190
Phys Rev Lett. 1996 Oct 14;77(16):3319-3322. doi: 10.1103/PhysRevLett.77.3319.

No abstract available.

Cite
Alessandrello A, Brofferio C, Bucci C, et al. Evidence for Naturally Occurring Electron Capture of 123Te. Phys Rev Lett. 1996;77(16):3319-3322doi: 10.1103/PhysRevLett.77.3319.
Alessandrello, A., Brofferio, C., Bucci, C., Camin, D. V., Caspani, P., Colling, P., Cremonesi, O., Fiorini, E., Giuliani, A., Nucciotti, A., Pavan, M., Pessina, G., Previtali, E., & Zanotti, L. (1996). Evidence for Naturally Occurring Electron Capture of 123Te. Physical review letters, 77(16), 3319-3322. https://doi.org/10.1103/PhysRevLett.77.3319
Alessandrello, et al. "Evidence for Naturally Occurring Electron Capture of 123Te." Physical review letters vol. 77,16 (1996): 3319-3322. doi: https://doi.org/10.1103/PhysRevLett.77.3319
Alessandrello A, Brofferio C, Bucci C, Camin DV, Caspani P, Colling P, Cremonesi O, Fiorini E, Giuliani A, Nucciotti A, Pavan M, Pessina G, Previtali E, Zanotti L. Evidence for Naturally Occurring Electron Capture of 123Te. Phys Rev Lett. 1996 Oct 14;77(16):3319-3322. doi: 10.1103/PhysRevLett.77.3319. PMID: 10062190.
Copy Download .nbib Format: NLM
Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor.

Clinical sarcoma research

Provenzano S, Raimondi A, Bertulli RM, Colia V, Renne SL, Collini P, Dagrada G, Callegaro D, Fiore M, Greco FG, Casali PG.
PMID: 29299229
Clin Sarcoma Res. 2017 Dec 28;7:20. doi: 10.1186/s13569-017-0086-2. eCollection 2017.

BACKGROUND: Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm of uncertain lineage and intermediate biological potential. It is more common in middle-aged men, usually arising from the deep tissues of the extremities. It is now established that...

Cite
Provenzano S, Raimondi A, Bertulli RM, et al. Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor. Clin Sarcoma Res. 2017;7:20doi: 10.1186/s13569-017-0086-2.
Provenzano, S., Raimondi, A., Bertulli, R. M., Colia, V., Renne, S. L., Collini, P., Dagrada, G., Callegaro, D., Fiore, M., Greco, F. G., & Casali, P. G. (2017). Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor. Clinical sarcoma research, 720. https://doi.org/10.1186/s13569-017-0086-2
Provenzano, Salvatore, et al. "Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor." Clinical sarcoma research vol. 7 (2017): 20. doi: https://doi.org/10.1186/s13569-017-0086-2
Provenzano S, Raimondi A, Bertulli RM, Colia V, Renne SL, Collini P, Dagrada G, Callegaro D, Fiore M, Greco FG, Casali PG. Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor. Clin Sarcoma Res. 2017 Dec 28;7:20. doi: 10.1186/s13569-017-0086-2. eCollection 2017. PMID: 29299229; PMCID: PMC5745994.
Copy Download .nbib Format: NLM
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience.

Clinical sarcoma research

Marchesi E, Cagnazzo C, Quattrini I, Leopardi MP, Villa C, Grignani G, D'Ambrosio L, Stacchiotti S, Casali PG, Picci P.
PMID: 28261443
Clin Sarcoma Res. 2017 Feb 28;7:4. doi: 10.1186/s13569-017-0068-4. eCollection 2017.

BACKGROUND: The Italian Sarcoma Group (ISG) is a nonprofit group of professionals established in 1997 aimed to improve the quality of care and promote the independent research in sarcomas. The increased regulatory requirements, the chance to increase the number...

Cite
Marchesi E, Cagnazzo C, Quattrini I, et al. How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clin Sarcoma Res. 2017;7:4doi: 10.1186/s13569-017-0068-4.
Marchesi, E., Cagnazzo, C., Quattrini, I., Leopardi, M. P., Villa, C., Grignani, G., D'Ambrosio, L., Stacchiotti, S., Casali, P. G., & Picci, P. (2017). How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clinical sarcoma research, 74. https://doi.org/10.1186/s13569-017-0068-4
Marchesi, Emanuela, et al. "How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience." Clinical sarcoma research vol. 7 (2017): 4. doi: https://doi.org/10.1186/s13569-017-0068-4
Marchesi E, Cagnazzo C, Quattrini I, Leopardi MP, Villa C, Grignani G, D'Ambrosio L, Stacchiotti S, Casali PG, Picci P. How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clin Sarcoma Res. 2017 Feb 28;7:4. doi: 10.1186/s13569-017-0068-4. eCollection 2017. PMID: 28261443; PMCID: PMC5329913.
Copy Download .nbib Format: NLM
Impact of Fabric Properties on Textile Pressure Sensors Performance.

Sensors (Basel, Switzerland)

Possanzini L, Tessarolo M, Mazzocchetti L, Campari EG, Fraboni B.
PMID: 31661929
Sensors (Basel). 2019 Oct 28;19(21). doi: 10.3390/s19214686.

In recent years, wearable technologies have attracted great attention in physical and chemical sensing applications. Wearable pressure sensors with high sensitivity in low pressure range (

Cite
Possanzini L, Tessarolo M, Mazzocchetti L, et al. Impact of Fabric Properties on Textile Pressure Sensors Performance. Sensors (Basel). 2019;19(21)doi: 10.3390/s19214686.
Possanzini, L., Tessarolo, M., Mazzocchetti, L., Campari, E. G., & Fraboni, B. (2019). Impact of Fabric Properties on Textile Pressure Sensors Performance. Sensors (Basel, Switzerland), 19(21), . https://doi.org/10.3390/s19214686
Possanzini, Luca, et al. "Impact of Fabric Properties on Textile Pressure Sensors Performance." Sensors (Basel, Switzerland) vol. 19,21 (2019). doi: https://doi.org/10.3390/s19214686
Possanzini L, Tessarolo M, Mazzocchetti L, Campari EG, Fraboni B. Impact of Fabric Properties on Textile Pressure Sensors Performance. Sensors (Basel). 2019 Oct 28;19(21). doi: 10.3390/s19214686. PMID: 31661929; PMCID: PMC6864692.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 135 entries